Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Imhof, Alexander
2003.
Vol. 26,
Issue. ,
p.
271.
Jacobs, Peter
Conforti, Anita
Wood, Lucille
Kiuru, Anne
Jones, Gareth O.
and
Woolf, Desmond
2004.
Immune Agranulocytosis and Clarithromycin.
Hematology,
Vol. 9,
Issue. 4,
p.
291.
Yilmaz, Ismail
Yilmazer, Cuneyt
Erkan, Alper Nabi
Aslan, Sundus Gencay
and
Ozluoglu, Levent N.
2005.
Intratympanic dexamethasone injection effects on transient-evoked otoacoustic emission.
American Journal of Otolaryngology,
Vol. 26,
Issue. 2,
p.
113.
Coulston, J
and
Balaratnam, N
2005.
Irreversible sensorineural hearing loss due to clarithromycin.
Postgraduate Medical Journal,
Vol. 81,
Issue. 951,
p.
58.
2006.
Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions.
p.
2183.
Yorgason, Joshua G
Fayad, Jose N
and
Kalinec, Federico
2006.
Understanding drug ototoxicity: molecular insights for prevention and clinical management.
Expert Opinion on Drug Safety,
Vol. 5,
Issue. 3,
p.
383.
Rybak, Leonard P.
2010.
Cummings Otolaryngology - Head and Neck Surgery.
p.
2169.
Gordon, Claire
and
Van Bambeke, Françoise
2010.
Kucers' The Use of Antibiotics Sixth Edition.
p.
801.
Yorgason, Joshua G
Luxford, William
and
Kalinec, Federico
2011.
In vitroandin vivomodels of drug ototoxicity: studying the mechanisms of a clinical problem.
Expert Opinion on Drug Metabolism & Toxicology,
Vol. 7,
Issue. 12,
p.
1521.
Whittemore, Kenneth R.
Dornan, Briana K.
and
Kenna, Margaret A.
2011.
Another cause of ototoxicity: Clarithromycin.
International Journal of Pediatric Otorhinolaryngology Extra,
Vol. 6,
Issue. 4,
p.
419.
2016.
Meyler's Side Effects of Drugs.
p.
710.
Heffernan, Colleen B.
McKeon, Mallory G.
Molony, Sasha
Kawai, Kosuke
Stiles, Derek J.
Lachenauer, Catherine S.
Kenna, Margaret A.
and
Watters, Karen
2018.
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children.
Annals of Otology, Rhinology & Laryngology,
Vol. 127,
Issue. 10,
p.
687.
Alrwisan, Adel
Antonelli, Patrick J.
Brumback, Babette A.
Wei, Yu-Jung
and
Winterstein, Almut G.
2018.
Azithromycin and Sensorineural Hearing Loss in Adults: A Retrospective Cohort Study.
Otology & Neurotology,
Vol. 39,
Issue. 8,
p.
957.
Coffin, Allison B.
Boney, Robert
Hill, Jordan
Tian, Cong
and
Steyger, Peter S.
2021.
Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings.
Frontiers in Neurology,
Vol. 12,
Issue. ,
Rybak, Leonard P.
Ramkumar, Vickram
and
Mukherjea, Debashree
2021.
Ototoxicity of Non-aminoglycoside Antibiotics.
Frontiers in Neurology,
Vol. 12,
Issue. ,
Gainville, Adrien
Rousseau, Vanessa
Kaguelidou, Florentia
Gervoise, Marie Boyer
Michot, Joëlle
Pizzoglio-Bellaudaz, Véronique
Chebane, Leila
Weckel, Alexandra
Montastruc, Jean-Louis
and
Durrieu, Geneviève
2021.
Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database.
Pediatric Drugs,
Vol. 23,
Issue. 1,
p.
87.
Vanoverschelde, Anna
Oosterloo, Berthe C
Ly, Nelly F
Ikram, M Arfan
Goedegebure, André
Stricker, Bruno H
and
Lahousse, Lies
2021.
Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss.
Journal of Antimicrobial Chemotherapy,
Vol. 76,
Issue. 10,
p.
2708.
Perletti, Gianpaolo
Trinchieri, Alberto
Stamatiou, Konstantinos
and
Magri, Vittorio
2022.
Safety considerations with new antibacterial approaches for chronic bacterial prostatitis.
Expert Opinion on Drug Safety,
Vol. 21,
Issue. 2,
p.
171.
Özgür Gündeşlioğlu, Özlem
Alabaz, Derya
and
Stimes, Grant T.
2023.
Hearing Loss in Congenital, Neonatal and Childhood Infections.
p.
1051.
Muhi, Stephen
Marshall, Julia L.
O'Brien, Daniel P.
Johnson, Paul D.R.
Ross, Gayle
Ramakrishnan, Anand
Mackay, Laura K.
Doerflinger, Marcel
McCarthy, James S.
Jamrozik, Euzebiusz
Osowicki, Joshua
and
Stinear, Timothy P.
2024.
A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection study..
Wellcome Open Research,
Vol. 9,
Issue. ,
p.
488.